Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACCELERATION: Contrast vs Adenosine FFR in PCI
NCT03557385Phase 4Completed
- Sponsor
- Duke University
- Start
- Jan 2019
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of iopamidol in coronary artery disease (CAD), sponsored by Duke University. Started Jan 2019; status: completed.
02
Drugs
iopamidol
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT03557385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03557385.